open access
In-vitro mechanical behavior and in-vivo healing response of a new generation biodegradable polymer-coated thin-strut sirolimus-eluting stents
Affiliations- Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
- 3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Silesian Centre for Heart Diseases, Zabrze, Poland
- Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, Silesian Center for Heart Diseases in Zabrze, Zabrze, Poland
- Charles River Laboratories, Montreal, Canada
open access
Abstract
Abstract
About this articleTitle
In-vitro mechanical behavior and in-vivo healing response of a new generation biodegradable polymer-coated thin-strut sirolimus-eluting stents
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Short communication
Pages
72-75
Published online
2021-11-05
Page views
4192
Article views/downloads
427
DOI
10.33963/KP.a2021.0158
Pubmed
Bibliographic record
Kardiol Pol 2022;80(1):72-75.
Authors
Paweł Gąsior
Łukasz Pyka
Michał Hawranek
Michał Garbacz
Madeline Chagnon
Diane Beaudry
Joanna Fluder
Mariusz Gąsior
Wojciech Wojakowski
Andrzej Lekston
References (10)- Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 2006; 47(1): 175–181.
- Park SJ, Kang SJ, Virmani R, et al. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol. 2012; 59(23): 2051–2057.
- Dores H, Raposo L, Campante Teles R, et al. Stent thrombosis with second- versus first-generation drug-eluting stents in real-world percutaneous coronary intervention: analysis of 3806 consecutive procedures from a large-volume single-center prospective registry. J Invasive Cardiol. 2013; 25(7): 330–336.
- Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011; 57(11): 1314–1322.
- Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006; 48(1): 193–202.
- Ng J, Foin N, Ang HY, et al. Over-expansion capacity and stent design model: An update with contemporary DES platforms. Int J Cardiol. 2016; 221: 171–179.
- Institute of Laboratory Animal Resources NRC. Principles of Care of Laboratory Animals. NIH Publication. No. 85–23 1996.
- Foin N, Sen S, Allegria E, et al. Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations? EuroIntervention. 2013; 8(11): 1315–1325.
- Sperling C, Waliszewski MW, Kherad B, et al. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries. Ther Adv Cardiovasc Dis. 2019; 13: 1753944719826335.
- Lim KS, Jeong MHo, Bae InHo, et al. Histopathological comparison among biolimus, zotarolimus and everolimus-eluting stents in porcine coronary restenosis model. Korean Circ J. 2013; 43(11): 744–751.
